![](/img/cover-not-exists.png)
198PA multicentre, international neoadjuvant (NA), randomized, double-blind phase III trial comparing fulvestrant to a combination of fulvestrant and palbociclib in patients with operable luminal breast cancer (SAFIA Trial)
Nabholtz, J-MA, Alsaleh, K A, Bounedjar, A, Oukkal, M, El-Zawahry, H M, Bouzid, K, Razek, H Abdel, Mahfouf, H, Bensalem, A, Saadeddin, A, Filali, T, Larbaoui, B, Abulkhair, O, Al-Foheidi, M, Boussen,Volume:
30
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz240.023
Date:
October, 2019
File:
PDF, 79 KB
english, 2019